Suppr超能文献

雄激素性脱发的药物治疗

Pharmacological Management of Pattern Hair Loss.

作者信息

Sattur Sandeep Suresh, Sattur Indu Sandeep

机构信息

HAIRREVIVE- Centre for Hair Restoration & Skin Rejuvenation, Santacruz West, Mumbai, Maharashtra, India.

出版信息

Indian J Plast Surg. 2021 Dec 13;54(4):422-434. doi: 10.1055/s-0041-1739254. eCollection 2021 Oct.

Abstract

Pattern hair loss (PHL) is a condition that worsens with time and the only way it can be slowed down is with pharmacological intervention. Pharmacological treatments for PHL, from an evidenced-based perspective with respect to safety and efficacy, are limited to only two drugs, minoxidil and finasteride. However, there are a host of drugs being used, off-label with limited evidence. This article attempts to review the literature on this topic, and the authors add to this, with their experience of over two decades on incorporating pharmacologic treatments along with hair transplantation in their management of PHL.

摘要

斑秃(PHL)是一种随时间推移而恶化的病症,唯一能减缓其发展的方法是进行药物干预。从安全性和有效性的循证角度来看,用于斑秃的药物治疗仅限于两种药物,即米诺地尔和非那雄胺。然而,目前有许多药物在无充分证据的情况下被超适应症使用。本文试图对该主题的文献进行综述,并且作者结合他们二十多年来在斑秃治疗中将药物治疗与毛发移植相结合的经验补充了相关内容。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2e1/8719956/6274d86a93c0/10-1055-s-0041-1739254-i2151262-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验